glp 1 medication and ms Medicare begins coverage of GLP-1 medications for obesity Ozempic and Multiple Sclerosis: Insights
Description
Some individuals also report changes in food cravings or preferences
Claims may be stronger when the injury resulted in long-term impairment, surgical procedures, significant financial losses, or permanent health limitations
Despite this, both deliberate and inadvertent use of these drugs is increasing, which has led to fetal exposure to these drugs in early pregnancy
In June 2025, Amgen announced positive Phase 2 trial results for MariTide showing up to ~20% weight loss in obese patients and ~17% in type 2 diabetes patients, presented at the ADA 85th scientific sessions
The basic plan starts at $149 per month and includes virtual doctor consultations, medication prescriptions, and access to the Noom app
A suggested protein target is included based on body weight
